HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter C Phillips Selected Research

retinoic acid receptor beta

2/2003Anti-proliferative effects of 20-epi-vitamin-D3 analogue, KH1060 in human neuroblastoma: induction of RAR-beta and p21(Cip1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter C Phillips Research Topics

Disease

10Brain Neoplasms (Brain Tumor)
12/2017 - 06/2002
7Neoplasms (Cancer)
01/2018 - 09/2003
5Medulloblastoma
01/2021 - 09/2003
3Glioma (Gliomas)
01/2016 - 04/2007
3Neuroblastoma
01/2006 - 02/2003
2Primitive Neuroectodermal Tumors (PNET)
12/2004 - 06/2002
1Hypersensitivity (Allergy)
01/2016
1Stroke (Strokes)
11/2012
1Cognitive Dysfunction
07/2012
1Carcinogenesis
01/2011
1Plexiform Neurofibroma
04/2008
1Headache (Headaches)
03/2006
1Arachnoiditis
03/2006
1Meningitis
03/2006
1Vomiting
03/2006
1Ototoxicity
12/2004
1Hypotension (Low Blood Pressure)
12/2004
1Hypocalcemia
12/2004
1Craniopharyngioma (Craniopharyngiomas)
03/2004

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2011 - 12/2003
2Biological ProductsIBA
01/2006 - 02/2003
2Cholecalciferol (Vitamin D3)FDA Link
01/2006 - 02/2003
1Carboplatin (JM8)FDA LinkGeneric
01/2016
1Retinaldehyde (Retinal)IBA
03/2011
1A-factor (Streptomyces)IBA
01/2011
1Histones (Histone)IBA
01/2011
1MicroRNAs (MicroRNA)IBA
01/2011
1Topotecan (Hycamtin)FDA LinkGeneric
01/2011
1Pharmaceutical PreparationsIBA
01/2011
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2008
1laromustine (VNP40101M)IBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2008
1Alkylating AgentsIBA
02/2008
1Temozolomide (Temodar)FDA LinkGeneric
04/2007
1Busulfan (Busulfex)FDA Link
03/2006
1dimemorfan (AT 17)IBA
03/2006
1RetinoidsIBA
01/2006
1FenretinideIBA
01/2006
1retinamideIBA
01/2006
1QW 1624F2-1IBA
01/2006
1seocalcitolIBA
01/2006
1Lomustine (CCNU)FDA Link
12/2004
1Cisplatin (Platino)FDA LinkGeneric
12/2004
1Vincristine (Oncovin)FDA LinkGeneric
12/2004
1Amifostine (Ethyol)FDA LinkGeneric
12/2004
1Messenger RNA (mRNA)IBA
12/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2003
1ParaffinIBA
12/2003
1LigandsIBA
12/2003
1Caspase 8 (Caspase-8)IBA
12/2003
1Caspase 9IBA
12/2003
1Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2003
1Caspase 3 (Caspase-3)IBA
09/2003
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2003
11,25-dihydroxyvitamin DIBA
06/2003
1hydroxide ionIBA
02/2003
1retinoic acid receptor betaIBA
02/2003
1KH 1060IBA
02/2003
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2002
1rofecoxib (Vioxx)FDA Link
06/2002
1Celecoxib (Celebrex)FDA Link
06/2002

Therapy/Procedure

5Radiotherapy
01/2021 - 03/2004
3Therapeutics
01/2018 - 01/2011
2Cranial Irradiation
04/2013 - 11/2012
2Drug Therapy (Chemotherapy)
12/2004 - 09/2003
1Craniospinal Irradiation
01/2021
1Adjuvant Chemotherapy
01/2021
1Heterologous Transplantation (Xenotransplantation)
01/2006